Contraindications and Restrictions
In addition, the gut-derived metabolite imidazole propionate has been shown to drive -synuclein pathology in preclinical and patient-derived PD models, providing a direct link between dysbiosis and -synuclein aggregation (103)
Antioxid Redox Signal 9 , 4989 (2007)
What theyre saying: While the new generation of incretin therapies have been revolutionary for patients living with obesity, bimagrumab addresses a critical unmet need as a therapeutic that targets fat loss while building muscle mass. Versanis CEO Mark Pruzanski The solo act The drug: Altimmunes pemvidutide is a combination GLP-1 agonist and glucagon agonist
Very rarely, there is pain, swelling, and scarring at the IV site in your arm
If you experience more severe side effects, tell your prescribing doctor